(S)-4,5,6,7-Tetrahydro-2,6-Benzothiazolediamine

A synthetic sequence documented in multiple drug master files (DMFs) confirms that this benzothiazole diamine functions as the sole chiral building block in the production of the non-ergoline dopamine agonist pramipexole. Regulatory inspections of commercial-scale active pharmaceutical ingredient (API) manufacturing suites operating under ICH Q7 and FDA 21 CFR Part 211 have established that the diamine’s enantiomeric excess directly determines the final API’s optical purity; consequently, incoming lot acceptance criteria require chiral HPLC (column: Chiralpak IA, 250 × 4.6 mm, 5 µm; mobile phase: n-hexane/ethanol/diethylamine 80/20/0.1 v/v/v; flow rate 1.0 mL/min) resolution of the (R) and (S) enantiomers with an area-normalised acceptance threshold of ≥99.5% ee. The stoichiometric addition ratio during reductive amination with propionaldehyde is maintained at 1.0–1.05 molar equivalents of aldehyde relative to the diamine to suppress formation of the bis-alkylated impurity tracked under monograph limits (USP Pramipexole Dihydrochloride RS and Ph. Eur. 10.8). Downstream processing is conducted in glass-lined reactors (nominal capacity 5,000–8,000 L) under a nitrogen blanket; a sodium triacetoxyborohydride-mediated reduction at –5°C to 0°C is followed by aqueous quench, solvent switch to isopropyl acetate, and hydrochloric acid gas precipitation to isolate pramipexole dihydrochloride monohydrate. Residual solvent profiles are routinely assessed via headspace GC-FID per USP <467>, with target limits of ≤500 ppm for isopropyl acetate and ≤290 ppm for methanol before the wet cake enters a conical vacuum dryer (≤10 mbar, jacket temperature 40–45°C) to reach a final loss-on-drying value of 6.5–7.5% w/w. Terminal dosage forms include immediate-release tablets at strengths of 0.125 mg, 0.25 mg, 0.5 mg, 1.0 mg, and 1.5 mg, where the diamine-derived moiety constitutes the pharmacologically active free-base backbone and batch genealogies are traceable through EDQM Certificates of Suitability (CEP) filings.

In continuous-roll manufacturing of colorless polyimide substrates for flexible organic light-emitting diode (OLED) displays, the incorporation of a chiral benzothiazole-based diamine as a co-monomer modifies the film’s out-of-plane retardation (R_th) to values below 5 nm at a thickness of 10 µm, a requirement for enhancing wide-angle contrast ratio under ambient lighting. The diamine—specifically (S)-4,5,6,7-tetrahydro-2,6-benzothiazolediamine—is dissolved in anhydrous N,N-dimethylacetamide (DMAc, water content ≤50 ppm) alongside 2,2′-bis(trifluoromethyl)-4,4′-diaminobiphenyl and pyromellitic dianhydride (PMDA) in a molar ratio that assigns 10–30 mol% of the total diamine fraction to the thiazole-containing monomer. The polymerisation is carried out in a jacketed 100 L planetary mixer (Inoue-type, with two vertical twisted blades and a bottom scraper) under a 10–15°C brine circulation to dissipate the exothermic anhydride ring-opening; after viscosity reaches 80,000–120,000 cP (Brookfield LV, spindle #7, 4 rpm), the polyamic acid solution is pressure-filtered through a 1 µm absolute-rated polypropylene depth cartridge and slot-die coated onto a stainless-steel endless belt with a gap precision of ±2 µm. Thermal imidization proceeds through a staged gradient oven: 80°C (solvent evaporation zone, residence 8 min), 150°C, 220°C, and final cure at 320°C (12 min) under a nitrogen atmosphere with oxygen concentration held below 10 ppm to prevent thermo-oxidative discoloration. The resulting film is tested per ASTM D882-18 for tensile modulus (typical range 3.5–4.2 GPa), ASTM D1003-21 for total light transmittance (≥88% at 400 nm), and ISO 15105-2 for oxygen transmission rate. Full REACH compliance is documented under registration numbers specific to individual EU legal entities, and the finished roll stock is die-cut into display-grade cover windows and backplane substrates for volume production of foldable smartphone panels.

Replacement of aliphatic C6–C12 diamines with the rigid benzothiazole diamine in a para-aramid backbone introduces a kink of approximately 158° along the polymer chain, as estimated from gas-phase semi-empirical PM7 geometry optimisation of the model compound. This structural distortion lowers the melting point of the resulting semi-aromatic polyamide to 275–285°C relative to >500°C for poly(p-phenylene terephthalamide), thereby enabling melt-processability on standard co-rotating twin-screw extrusion lines (L/D 40:1, screw diameter 25 mm, segmented screws with three kneading blocks). The chiral diamine is introduced at 50 mol% of the total diamine complement, with terephthalic acid and isophthalic acid in a 70/30 weight ratio providing the diacid component; a pre-polymerisation solid-state blending step with an organophosphite antioxidant (0.3 phr) is essential to suppress thermal crosslinking of the thiazole ring at temperatures above 290°C. Strands exiting a water bath (20°C) are pelletised to uniform cylinder dimensions (2.5 mm × 3.0 mm) and subsequently injection-moulded on an 80-tonne electrically-actuated machine with a variable-temperature mould (cavity surface 140°C, injection pressure 1,200 bar, hold time 8 s) to produce ISO multi-purpose test specimens. Mechanical properties are evaluated per ISO 527-2:2012 (tensile yield strength 95–105 MPa, elongation at break 4.5–6.0%) and ISO 179-1:2010 (Charpy notched impact 6–8 kJ/m² at 23°C). Certification of conformity to EU Directive 2011/65/EU (RoHS 3) and SCIP database submission is mandatory for moulded parts entering EU electrical and electronic equipment supply chains; end-use components include internal snap-fit clips, cam followers, and dielectric spacers in EV battery disconnect units where the combination of dimensional stability and inherent flame retardancy (UL 94 V-0 at 0.8 mm thickness) meets automotive OEM specifications.

In the synthesis of amine-functionalised metal-organic frameworks (MOFs) intended for enantioselective liquid-phase separations, the chirally pure benzothiazole diamine reacts with zirconium tetrachloride in the presence of 2-amino-1,4-benzenedicarboxylic acid under solvothermal conditions (DMF/H₂O 9/1 v/v, 120°C, 48 h) within a PTFE-lined autoclave (200 mL, fill volume 70%). The diamine occupies post-synthetic modification sites on the secondary building unit with a loading determined by ¹H NMR digestion of 5–8 mol% relative to the framework’s total linker content, imparting a specific chiral recognition pocket that exhibits a separation factor of 2.0–2.3 for racemic 1-phenylethanol in breakthrough column experiments with a mobile phase of n-heptane/isopropanol 98/2. The column (4.6 mm ID × 150 mm, stainless steel, slurry-packed at 400 bar) is conditioned for 12 h before injection, and back-pressure is maintained below 80 bar to prevent framework amorphisation. Published data for this specific configuration in continuous simulated moving-bed (SMB) operation is limited; academic feasibility demonstrations have not yet reproduced the robustness criteria required by ISO TS 19883:2017 for preparative chiral separations, though the underlying thermodynamic separation mechanism is sufficiently characterised to justify kilogram-scale diamine procurement by industrial chromatography service providers.